These are the posts from the How we think section that have been tagged with Dementia.
To see all tags used in our posts, click here.
| 18th January 2017
Content Marketing Manager Liz Inskip interviews Neil Maiden of City, University of London, about his work developing mobile technology solutions for residential dementia care, and what the challenges facing innovators in this therapy area are.
| 2nd September 2016
Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.
| 19th July 2016
In the last 13 years, only one new drug has been approved for patients with Alzheimer's Disease. The most recently approved drug was in 2014, bringing the total number of agents approved across AD to 5. In this article, Consultant David Cooney explores the success rate of trials in AD and the reasons for this incredulous situation, as well as look at the some of the glimmers of light at the end of the tunnel.